2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

被引：4228

作者：

Stone, Neil J.

Robinson, Jennifer G.

Lichtenstein, Alice H.

Merz, C. Noel Bairey

Blum, Conrad B.

Eckel, Robert H.

Goldberg, Anne C.

Gordon, David

Levy, Daniel

Lloyd-Jones, Donald M.

McBride, Patrick

Schwartz, J. Sanford

Shero, Susan T.

Smith, Sidney C., Jr.

Watson, Karol

Wilson, Peter W. F.

机构：

来源：

CIRCULATION | 2014年 / 129卷 / 25期

关键词：

AHA Scientific Statements; cardiovascular disease; cholesterol; hydroxymethylglutaryl-CoA reductase inhibitors/statins; primary prevention; secondary prevention; diabetes mellitus; drug therapy; risk assessment; risk reduction behavior; patient compliance; hypercholesterolemia; lipids; biomarkers; pharmacological; ACUTE CORONARY SYNDROMES; BASE-LINE CHARACTERISTICS; TYPE-2; DIABETES-MELLITUS; PRIMARY-PREVENTION TRIAL; HIGH-DOSE ATORVASTATIN; 14; RANDOMIZED-TRIALS; MYOCARDIAL-INFARCTION; STATIN THERAPY; SECONDARY PREVENTION; LDL CHOLESTEROL;

D O I：

10.1161/01.cir.0000437738.63853.7a

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S1 / S45

页数：45

共 138 条

[111] High-dose statin therapy for secondary prevention of stroke: Stroke prevention by aggressive reduction in cholesterol levels study review [J].

Schwertz, Dorie W. ;

Badellino, Karen O. .

JOURNAL OF CARDIOVASCULAR NURSING, 2008, 23 (01) :8-13

[112] Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention - A randomized controlled trial [J].

Serruys, PWJC ;

de Feyter, P ;

Macaya, C ;

Kokott, N ;

Puel, J ;

Vrolix, M ;

Branzi, A ;

Bertolami, MC ;

Jackson, G ;

Strauss, B ;

Meier, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (24) :3215-3222

[113] Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes:: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA) [J].

Sever, PS ;

Poulter, NR ;

Dahlöf, B ;

Wedel, H ;

Collins, R ;

Beevers, G ;

Caulfield, M ;

Kjeldsen, SE ;

Kristinsson, A ;

McInnes, GT ;

Mehlsen, J ;

Nieminen, M ;

O'Brien, E ;

Ostergren, J .

DIABETES CARE, 2005, 28 (05) :1151-1157

[114] Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease [J].

Baigent, C. ;

Landray, M. ;

Reith, C. ;

Dasgupta, T. ;

Emberson, J. ;

Herrington, W. ;

Lewis, D. ;

Mafham, M. ;

Collins, R. ;

Baigent, C. ;

Landray, M. ;

Bray, C. ;

Chen, Y. ;

Baxter, A. ;

Young, A. ;

Hill, M. ;

Knott, C. ;

Cass, A. ;

Feldt-Rasmussen, B. ;

Fellstroem, B. ;

Grobbee, R. ;

Groenhagen-Riska, C. ;

Haas, M. ;

Holdaas, H. ;

Hooi, L. S. ;

Jiang, L. ;

Kasiske, B. ;

Krairittichai, U. ;

Levin, A. ;

Massy, Z. ;

Tesar, V. ;

Walker, R. ;

Wanner, C. ;

Wheeler, D. ;

Wiecek, A. ;

Dasgupta, T. ;

Lewis, D. ;

Mafham, M. ;

Majoni, W. ;

Reith, C. ;

Simpson, D. ;

Strony, J. ;

Musliner, T. ;

Agodoa, L. ;

Armitage, J. ;

Chen, Z. ;

Craig, J. ;

de Zeeuw, D. ;

Gaziano, M. .

AMERICAN HEART JOURNAL, 2010, 160 (05) :785-U28

[115] Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [J].

Shepherd, J ;

Blauw, GJ ;

Murphy, MB ;

Bollen, ELEM ;

Buckley, BM ;

Cobbe, SM ;

Ford, I ;

Gaw, A ;

Hyland, M ;

Jukema, JW ;

Kamper, AM ;

Macfarlane, PW ;

Meinders, AE ;

Norrie, J ;

Packard, CJ ;

Perry, IJ ;

Stott, DJ ;

Sweeney, BJ ;

Twomey, C ;

Westendorp, RGJ .

LANCET, 2002, 360 (9346) :1623-1630

[116] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

[117]

Shepherd J, 2008, MAYO CLIN PROC, V83, P870

[118] Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease [J].

Shepherd, James ;

Kastelein, John J. P. ;

Bittrier, Vera ;

Deedwania, Prakash ;

Breazna, Andrei ;

Dobson, Stephen ;

Wilson, Daniel J. ;

Zuckerman, Andrea ;

Wenger, Nanette K. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (15) :1448-1454

[119] Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes - The treating to new targets (TNT) study [J].

Shepherd, James ;

Breazna, Andrei ;

Barter, Philip ;

LaRosa, John ;

Carmena, Rafael ;

Grundy, Scott ;

Deedwania, Prakash ;

Waters, David ;

Fruchart, Jean-Charles ;

Haffner, Steven ;

Hsia, Judith .

DIABETES CARE, 2006, 29 (06) :1220-1226

[120] Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes [J].

Stevens, R ;

Coleman, RL ;

Adler, AI ;

Stratton, IM ;

Matthews, DR ;

Holman, RR .

DIABETES CARE, 2004, 27 (01) :201-207

← 5 6 7 8 9 10 11 12 13 14 →